Align Technology Inc. (ALGN)
ALGN (NASDAQ:Health Services)
$36.70
-0.28
-0.76%
Today's Range: 36.15 - 36.99 |
ALGN Avg Daily Volume: 906,100
| Last Update: 05/24/13 - 4:00 PM EDT |
| Volume: 254,902 |
| YTD Performance: 34.41%
|
| Open: $36.62 |
| Previous Close: $36.98 |
| 52 Week Range: $23.45 -
$39.82 |
| Oustanding Shares: 81,557,143 |
| Market Cap: 3,042,081,434 |
6-Month Chart
TheStreet Ratings Grade for ALGN
| Buy |
Hold
|
Sell
|
| A+ |
A |
A- |
B+ |
B |
B- |
C+ |
C |
C- |
D+ |
D |
D- |
E+ |
E |
E- |
F |
Analysts Ratings
| Historical Rec |
Current |
1 Mo. Ago |
2 Mo. Ago |
3 Mo. Ago |
| Strong Buy |
8 |
9 |
9 |
9 |
| Moderate Buy |
0 |
0 |
0 |
0 |
| Hold |
3 |
3 |
3 |
3 |
| Moderate Sell |
0 |
0 |
0 |
0 |
| Strong Sell |
0 |
0 |
0 |
0 |
| Mean Rec. |
1.55 |
1.50 |
1.50 |
1.50 |
| Latest Dividend: |
0.00 |
| Latest Dividend Yield: |
0.00% |
| Dividend Ex-Date: |
12/31/69 |
| Price Earnings Ratio: |
-532.86 |
|
| Price Earnings Comparisons: |
| ALGN |
Sector Avg. |
S&P 500 |
| -532.86 |
0.00 |
17.70 |
| Price Performance History (%Change): |
| 3 Mo |
1 Yr |
3 Y |
|
17.00%
|
18.49%
|
135.18%
|
|
| GROWTH |
12 Mo |
3 Yr |
CAGR |
| Revenue |
16.70 |
0.79 |
0.21 |
| Net Income |
-12.00 |
-2.88 |
0.00 |
| EPS |
-14.50 |
-2.62 |
0.00 |
| Earnings for ALGN: |
| EBITDA |
0.14B |
| Revenue |
0.56B |
|
Average Earnings Estimates
;Qtr (09/13);FY (12/13);FY (12/14)&HEADING_LIST1=Qtr (06/12);Qtr (09/12);FY (12/12);FY (12/13)) |
|
| Average Estimate |
$0.28 |
$0.31 |
$1.19 |
$1.45 |
| Number of Analysts |
10 |
10 |
10 |
10 |
| High Estimate |
$0.32 |
$0.34 |
$1.30 |
$1.66 |
| Low Estimate |
$0.26 |
$0.26 |
$1.06 |
$1.21 |
| Prior Year |
$0.34 |
$0.28 |
$1.17 |
$1.19 |
| Growth Rate (Year over Year) |
-17.06% |
9.29% |
1.79% |
21.91% |
Jan 31, 2013 | 8:14 AM EST
Shares of ALGN now seen reaching $36, Jefferies said. Estimates also raised on demand trends re-accelerating. Buy rating.
Jan 03, 2013 | 8:26 AM EST
ALGN was upgraded from Underweight to Equal-weight, Morgan Stanley said. Company should see better consumer trends and easing competiti...
Oct 18, 2012 | 8:41 AM EDT
Shares of ALGN now seen reaching $34, Jefferies said. Estimates also lowered on rare 3Q shortfall. Buy rating.
Oct 18, 2012 | 7:17 AM EDT
Shares of ALGN now seen reaching $30, according to Credit Suisse. Estimates also cut, as the company is seeing lower case shipment grow...
| Jul 19, 2012 | 1:40 PM EDT
Align Technology's options are pricing in a 12% move.
| Jun 27, 2012 | 11:00 AM EDT
Coinstar and VeriSign have a chance of outperforming if the market ramps up again.
| Jun 11, 2012 | 2:10 PM EDT
These two stocks have performed particularly well lately.
May 22, 2012 | 6:46 AM EDT
Coverage of ALGN was started with a Buy rating, Cantor Fitzgerald said. $37 price target. Company has a competitive advantage in a fast...
Apr 24, 2012 | 8:18 AM EDT
Shares of ALGN now seen reaching $34, Jefferies said. Estimates also raised on higher cash flow forecast. Buy rating.
Jan 31, 2012 | 7:13 AM EST
ALGN estimates were raised through 2013, Credit Suisse said. Company is realizing higher volume growth. Neutral rating and new $25 pric...
